Related Experiment Videos
Diverse hematologic effects of parvovirus B19 infection
1Department of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudia Arabia.
Insights
Human parvovirus B19 can cause various blood disorders in children, including aplastic crises and cytopenias. Screening for B19 and treating with intravenous gamma globulin can resolve abnormal blood counts when other therapies fail.
Area of Science:
- Hematology
- Virology
- Pediatrics
Background:
- Human parvovirus B19 is increasingly recognized for its association with a diverse range of hematologic conditions.
- These conditions include aplastic crises, neutropenia, thrombocytopenia, and hemophagocytic syndromes.
Purpose of the Study:
- To highlight the association between Human parvovirus B19 and various hematologic disorders.
- To emphasize the importance of screening children with cytopenias for B19 infection.
Main Methods:
- The abstract does not specify methods, but implies clinical observation and case review.
- Focus is on identifying B19 as a causative agent and evaluating treatment outcomes.
Main Results:
- Human parvovirus B19 is linked to a spectrum of hematologic abnormalities.
- Intravenous gamma globulin (IVGG) can be an effective treatment for B19-induced cytopenias.
Conclusions:
- Children presenting with cytopenias should be evaluated for Human parvovirus B19 infection.
- IVGG offers a potential therapeutic option for resolving abnormal blood counts when transfusions are insufficient or undesirable.
Abstract:
Human parvovirus B19 is linked with a broadening spectrum of hematologic disorders, including aplastic crises in the context of hemolytic anemias, neutropenia, thrombocytopenia, and hemophagocytic syndromes. Children with any of these cytopenias should be screened for the presence of B19 because treatment with intravenous gamma globulin may provide resolution of abnormal blood counts if other therapeutic options, such as transfusion, are not adequate or desired.